Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA

BACKGROUND: Metformin is a widely used oral hypoglycemizing agent recently proposed as potential anti-cancer drug. In this study we report the antiproliferative effect of metformin treatment in a high risk neuroblastoma cell model, focusing on possible effects associated to different levels of diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Delfina, Gigoni, Arianna, Würth, Roberto, Cancedda, Ranieri, Florio, Tullio, Pagano, Aldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128937/
https://www.ncbi.nlm.nih.gov/pubmed/25120382
http://dx.doi.org/10.1186/1475-2867-14-59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128937/
https://www.ncbi.nlm.nih.gov/pubmed/25120382
http://dx.doi.org/10.1186/1475-2867-14-59

Ejemplares similares